The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Genetics and the placebo effect: the placebome
Open accessAbstract
Placebos are indispensable controls in randomized clinical trials (RCTs), and placebo responses significantly contribute to routine clinical outcomes. Recent neurophysiological studies reveal neurotransmitter pathways that mediate placebo effects. Evidence that genetic variations in these pathways can modify placebo effects raises the possibility of using genetic screening to identify placebo responders and thereby increase RCT efficacy and improve therapeutic care. Furthermore, the possibility of interaction between placebo and drug molecular pathways warrants consideration in RCT design. The study of genomic effects on placebo response, “the placebome”, is in its infancy. Here, we review evidence from placebo studies and RCTs to identify putative genes in the placebome, examine evidence for placebo-drug interactions, and discuss implications for RCTs and clinical care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
dbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307
Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788
Interactome Networks and Human Disease
Vidal, M., Cusick, M. E., & Barabási, A.-L. (2011) · Cell · doi:10.1016/j.cell.2011.02.016 · Cited by 1,771
Uncovering disease-disease relationships through the incomplete interactome
Menche, J., Sharma, A., Kitsak, M., Ghiassian, S. D., Vidal, M., Loscalzo, J., & Barabási, A.-L. (2015) · Science · doi:10.1126/science.1257601 · Cited by 1,546
Self-citationBiological, clinical, and ethical advances of placebo effects
Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61706-2 · Cited by 1,272
Self-citationComponents of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
Kaptchuk, T. J., Kelley, J. M., Conboy, L. A., Davis, R. B., Kerr, C. E., Jacobson, E. E., Kirsch, I., Schyner, R. N., Nam, B. H., Nguyen, L. T., et al. (2008) · BMJ · doi:10.1136/bmj.39524.439618.25 · Cited by 1,196
Self-citationExpectation and Dopamine Release: Mechanism of the Placebo Effect in Parkinson's Disease
de la Fuente-Fernández, R., Ruth, T. J., Sossi, V., Schulzer, M., Calne, D. B., & Stoessl, A. J. (2001) · Science · doi:10.1126/science.1060937 · Cited by 991
Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
Kaptchuk, T. J., Friedlander, E., Kelley, J. M., Sanchez, M. N., Kokkotou, E., Singer, J. P., Kowalczykowski, M., Miller, F. G., Kirsch, I., & Lembo, A. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015591 · Cited by 900
Self-citationAmanzio, M., & Benedetti, F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-01-00484.1999 · Cited by 899
Bouthenet, M.-L., Souil, E., Martres, M.-P., Sokoloff, P., Giros, B., & Schwartz, J.-C. (1991) · Brain Research · doi:10.1016/0006-8993(91)91456-b · Cited by 868
Placebo Effects Mediated by Endogenous Opioid Activity on μ-Opioid Receptors
Zubieta, J.-K., Bueller, J. A., Jackson, L. R., Scott, D. J., Xu, Y., Koeppe, R. A., Nichols, T. E., & Stohler, C. S. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0439-05.2005 · Cited by 779
The Functional Neuroanatomy of the Placebo Effect
Mayberg, H. S., Silva, J. A., Brannan, S. K., Tekell, J. L., Mahurin, R. K., McGinnis, S., & Jerabek, P. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.728 · Cited by 720
Placebo and Nocebo Effects Are Defined by Opposite Opioid and Dopaminergic Responses
Scott, D. J., Stohler, C. S., Egnatuk, C. M., Wang, H., Koeppe, R. A., & Zubieta, J.-K. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.34 · Cited by 637
Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network
Bingel, U., Lorenz, J., Schoell, E., Weiller, C., & Büchel, C. (2006) · Pain · doi:10.1016/j.pain.2005.08.027 · Cited by 567
Allelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G
Zhang, Y., Wang, D., Johnson, A. D., Papp, A. C., & Sadée, W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504942200 · Cited by 563
Price, D. D., Milling, L. S., Kirsch, I., Duff, A., Montgomery, G. H., & Nicholls, S. S. (1999) · Pain · doi:10.1016/s0304-3959(99)00081-0 · Cited by 561
Placebo and the New Physiology of the Doctor-Patient Relationship
Benedetti, F. (2013) · Physiological Reviews · doi:10.1152/physrev.00043.2012 · Cited by 492
Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype
Meyer-Lindenberg, A., Kohn, P. D., Kolachana, B., Kippenhan, S., McInerney-Leo, A., Nussbaum, R., Weinberger, D. R., & Berman, K. F. (2005) · Nature Neuroscience · doi:10.1038/nn1438 · Cited by 428
The role of learning in nocebo and placebo effects
Colloca, L., Sigaudo, M., & Benedetti, F. (2008) · Pain · doi:10.1016/j.pain.2008.02.006 · Cited by 411
Altered Placebo and Drug Labeling Changes the Outcome of Episodic Migraine Attacks
Kam-Hansen, S., Jakubowski, M., Kelley, J. M., Kirsch, I., Hoaglin, D. C., Kaptchuk, T. J., & Burstein, R. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3006175 · Cited by 399
Self-citationChanges in Brain Function of Depressed Subjects During Treatment With Placebo
Leuchter, A. F., Cook, I. A., Witte, E. A., Morgan, M., & Abrams, M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.122 · Cited by 396
Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia
Kanasaki, K., Palmsten, K., Sugimoto, H., Ahmad, S., Hamano, Y., Xie, L., Parry, S., Augustin, H. G., Gattone, V. H., Folkman, J., et al. (2008) · Nature · doi:10.1038/nature06951 · Cited by 381
Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles
Palmatier, M. A., Kang, A. M., & Kidd, K. K. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00098-0 · Cited by 381
Rakvåg, T. T., Klepstad, P., Baar, C., Kvam, T.-M., Dale, O., Kaasa, S., Krokan, H. E., & Skorpen, F. (2005) · Pain · doi:10.1016/j.pain.2005.03.032 · Cited by 347
Active Albuterol or Placebo, Sham Acupuncture, or No Intervention in Asthma
Wechsler, M. E., Kelley, J. M., Boyd, I. O. E., Dutile, S., Marigowda, G., Kirsch, I., Israel, E., & Kaptchuk, T. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103319 · Cited by 344
Self-citation‘Powerful Placebo: The Dark Side of the Randomised Controlled Trial’
Kaptchuk, T. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10111-8 · Cited by 339
Self-citationDopamine D3Receptors Expressed by All Mesencephalic Dopamine Neurons
Diaz, J., Pilon, C., Le Foll, B., Gros, C., Triller, A., Schwartz, J.-C., & Sokoloff, P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08677.2000 · Cited by 326
Influence of the method of drug administration on analgesic response
Levine, J. D., & Gordon, N. C. (1984) · Nature · doi:10.1038/312755a0 · Cited by 323
Effects of Expectation on Placebo-Induced Dopamine Release in Parkinson Disease
Lidstone, S. C., Schulzer, M., Dinelle, K., Mak, E., Sossi, V., Ruth, T. J., de la Fuente-Fernández, R., Phillips, A. G., & Stoessl, A. J. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.88 · Cited by 323
Intentional Ignorance: A History of Blind Assessment and Placebo Controls in Medicine
Kaptchuk, T. J. (1998) · Bulletin of the History of Medicine · doi:10.1353/bhm.1998.0159 · Cited by 314
Self-citationBenedetti, F. (1996) · Pain · doi:10.1016/0304-3959(95)00179-4 · Cited by 297
Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors
Benedetti, F., Amanzio, M., Rosato, R., & Blanchard, C. (2011) · Nature Medicine · doi:10.1038/nm.2435 · Cited by 289
The placebo effect in irritable bowel syndrome trials: a meta‐analysis1
Patel, S. M., Stason, W. B., Legedza, A., Ock, S. M., Kaptchuk, T. J., Conboy, L., Canenguez, K., Park, J. K., Kelly, E., Jacobson, E., et al. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00650.x · Cited by 285
Self-citationGatt, J. M., Burton, K. L. O., Williams, L. M., & Schofield, P. R. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.09.014 · Cited by 279
Neurobiological Mechanisms of Placebo Responses
Zubieta, J., & Stohler, C. S. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04424.x · Cited by 277
Altar, C. A., Boylan, C. B., Jackson, C., Hershenson, S., Miller, J., Wiegand, S. J., Lindsay, R. M., & Hyman, C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11347 · Cited by 275
Placebo Effects – Understanding the Mechanisms in Health and Disease
(2016) · physioscience · doi:10.1055/s-0035-1567078 · Cited by 270
Yavich, L., Forsberg, M. M., Karayiorgou, M., Gogos, J. A., & Männistö, P. T. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0665-07.2007 · Cited by 269
The narcotic antagonist naloxone enhances clinical pain
LEVINE, J. D., GORDON, N. C., JONES, R. T., & FIELDS, H. L. (1978) · Nature · doi:10.1038/272826a0 · Cited by 261
Human monoamine oxidase A gene determines levels of enzyme activity.
Hotamışlıgil, G. S., & Breakefield, X. O. (1991) · PubMed · Cited by 260
Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide
Benedetti, F., Amanzio, M., Casadio, C., Oliaro, A., & Maggi, G. (1997) · Pain · doi:10.1016/s0304-3959(97)03346-0 · Cited by 238
Placebo Effects: Understanding the Mechanisms in Health and Disease
Ernst, E. (2009) · Focus on Alternative and Complementary Therapies · doi:10.1111/j.2042-7166.2009.tb05272.x · Cited by 227
Potentiation of placebo analgesia by proglumide
Benedetti, F., Amanzio, M., & Maggi, G. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92938-x · Cited by 221
Kroslak, T., LaForge, K. S., Gianotti, R. J., Ho, A., Nielsen, D. A., & Kreek, M. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04738.x · Cited by 213
Furmark, T., Appel, L., Henningsson, S., Åhs, F., Faria, V., Linnman, C., Pissiota, A., Frans, Ö., Bani, M., Bettica, P., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2534-08.2008 · Cited by 210
Hall, K. T., Lembo, A. J., Kirsch, I., Ziogas, D. C., Douaiher, J., Jensen, K. B., Conboy, L. A., Kelley, J. M., Kokkotou, E., & Kaptchuk, T. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048135 · Cited by 205
Self-citationOpen-Label Placebo for Major Depressive Disorder: A Pilot Randomized Controlled Trial
Kelley, J. M., Kaptchuk, T. J., Cusin, C., Lipkin, S., & Fava, M. (2012) · Psychotherapy and Psychosomatics · doi:10.1159/000337053 · Cited by 190
Self-citationStraube, S., Derry, S., McQuay, H. J., & Moore, R. A. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03200.x · Cited by 173
Analgesic responses to morphine and placebo in individuals with postoperative pain
Levine, J. D., Gordon, N. C., Smith, J., & Fields, H. L. (1981) · Pain · doi:10.1016/0304-3959(81)90099-3 · Cited by 167
Peciña, M., Love, T., Stohler, C. S., Goldman, D., & Zubieta, J.-K. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.272 · Cited by 164
Tchivileva, I. E., Lim, P. F., Smith, S. B., Slade, G. D., Diatchenko, L. B., McLean, S. A., & Maixner, W. D. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328337f9ab · Cited by 163
Atlas, L. Y., & Wager, T. D. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-44519-8_3 · Cited by 162
Miczek, K. A., Nikulina, E. M., Shimamoto, A., & Covington, H. E. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0637-11.2011 · Cited by 162
Farrell, S., Tunbridge, E. M., Braeutigam, S., & Harrison, P. J. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.023 · Cited by 160
Rakvåg, T. T. N., Ross, J. R., Sato, H., Skorpen, F., Kaasa, S., & Klepstad, P. (2008) · Molecular Pain · doi:10.1186/1744-8069-4-64 · Cited by 160
Hohmann, A. G. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00154-8 · Cited by 159
Prediction of placebo responses: a systematic review of the literature
Horing, B., Weimer, K., Muth, E. R., & Enck, P. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.01079 · Cited by 155
Giakoumaki, S. G., Roussos, P., & Bitsios, P. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.82 · Cited by 151
Do “placebo responders” exist?
Kaptchuk, T. J., Kelley, J. M., Deykin, A., Wayne, P. M., Lasagna, L. C., Epstein, I. O., Kirsch, I., & Wechsler, M. E. (2008) · Contemporary Clinical Trials · doi:10.1016/j.cct.2008.02.002 · Cited by 151
Self-citationVaccarino, V., Brennan, M., Miller, A. H., Bremner, J. D., Ritchie, J., Lindau, F., Veledar, E., Su, S., Murrah, N. V., Jones, L., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.023 · Cited by 150
Mechanisms of the placebo response and their impact on clinical trials and clinical practice
Finniss, D. G., & Benedetti, F. (2005) · Pain · doi:10.1016/j.pain.2004.12.012 · Cited by 150
Weickert, T. W., Goldberg, T. E., Mishara, A. L., Apud, J. A., Kolachana, B. S., Egan, M. F., & Weinberger, D. R. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.012 · Cited by 142
New Approaches to Molecular Diagnosis
Korf, B. R., & Rehm, H. L. (2013) · JAMA · doi:10.1001/jama.2013.3239 · Cited by 141
Goggi, J., Pullar, I. A., Carney, S. L., & Bradford, H. F. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02505-2 · Cited by 134
Leuchter, A. F., McCracken, J. T., Hunter, A. M., Cook, I. A., & Alpert, J. E. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181ac4aaf · Cited by 131
Lee, S., Walker, J. R., Jakul, L., & Sexton, K. A. (2004) · Depression and Anxiety · doi:10.1002/da.10134 · Cited by 113
FAAH selectively influences placebo effects
Peciña, M., Martínez-Jauand, M., Hodgkinson, C. A., Stohler, C. S., Goldman, D. A., & Zubieta, J. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.124 · Cited by 110
Hazin, R., Brothers, K. B., Malin, B., Koenig, B. A., Sanderson, S. C., Rothstein, M. A., Williams, M. S., Clayton, E. W., & Kullo, I. J. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.117 · Cited by 109
Białecka, M. A., Kurzawski, M., Kłodowska-Duda, G. A., Opala, G., Tan, E., & Droździk, M. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328306c2f2 · Cited by 101
Mechanisms of the placebo response
Benedetti, F., & Amanzio, M. (2013) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2013.01.006 · Cited by 93
Methodological issues in clinical trials of opioids for chronic pain
Katz, N. P. (2005) · Neurology · doi:10.1212/wnl.65.12_suppl_4.s32 · Cited by 92
Annerbrink, K., Westberg, L., Nilsson, S., et al. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.012 · Cited by 85
Yu, R., Gollub, R. L., Vangel, M. G., Kaptchuk, T. J., Smoller, J. W., & Kong, J. (2014) · Human Brain Mapping · doi:10.1002/hbm.22496 · Cited by 84
Self-citationEssential elements of personalized medicine
Burke, W., Trinidad, S. B., & Press, N. A. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2013.09.002 · Cited by 80
McLeod, H. L., Fang, L., Luo, X., Scott, E. P., & Evans, W. E. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22361-8 · Cited by 78
Ormond, K. E., & Cho, M. K. (2014) · Personalized Medicine · doi:10.2217/pme.13.104 · Cited by 71
Peciña, M., Martínez-Jauand, M., Love, T., Heffernan, J., Montoya, P., Hodgkinson, C. A., Stohler, C. S., Goldman, D. A., & Zubieta, J.-K. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2152-13.2014 · Cited by 60
A genome-wide association study of a sustained pattern of antidepressant response
Hunter, A. M., Leuchter, A. F., Power, R. A., Muthén, B., McGrath, P. J., Lewis, C. M., Cook, I. A., Garriock, H. A., McGuffin, P., Uher, R., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.002 · Cited by 59
Monoamine Oxidase A Genotype Predicts Human Serotonin 1A Receptor AvailabilityIn Vivo
Mickey, B. J., Ducci, F., Hodgkinson, C. A., Langenecker, S. A., Goldman, D. A., & Zubieta, J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2391-08.2008 · Cited by 56
Caspi, O., & Bootzin, R. R. (2002) · Evaluation & the Health Professions · doi:10.1177/0163278702238056 · Cited by 56
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine
Antman, E. M., Weiss, S. T., & Loscalzo, J. (2012) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1173 · Cited by 54
Self-citationHamidovic, A., Dlugos, A. M., Palmer, A. A., & de Wit, H. (2010) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32833a1f3c · Cited by 53
Developing New Drug Treatments in the Era of Network Medicine
Silverman, E. K., & Loscalzo, J. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.207 · Cited by 50
Self-citationWendt, L., Albring, A., Benson, S., Engler, H., Engler, A., Hinney, A., Rief, W., Witzke, O., & Schedlowski, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107665 · Cited by 47
Platelet-Mediated Metabolism of the Common Dietary Flavonoid, Quercetin
Wright, B., Gibson, T., Spencer, J., Lovegrove, J., & Gibbins, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009673 · Cited by 46
Analysis of 34 candidate genes in bupropion and placebo remission
Tiwari, A. K., Zai, C. C. H., Sajeev, G., Arenovich, T., Müller, D. J., & Kennedy, J. L. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000843 · Cited by 45
Hall, K. T., Nelson, C. P., Davis, R. B., Buring, J. E., Kirsch, I., Mittleman, M. A., Loscalzo, J., Samani, N. J., Ridker, P. M., Kaptchuk, T. J., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303845 · Cited by 42
Self-citationPharmacogenetics of naltrexone and disulfiram in alcohol dependent, dually diagnosed veterans
Arias, A. J., Gelernter, J. E., Gueorguieva, R. V., Ralevski, E., & Petrakis, I. L. (2014) · American Journal on Addictions · doi:10.1111/j.1521-0391.2014.12102.x · Cited by 37
Chen, A. C. H., & Kuerbis, C. M. D. A. N. (2013) · Journal of Alcoholism and Drug Dependence · doi:10.4172/2329-6488.1000101 · Cited by 21
Tolcapone, COMT Polymorphisms and Pharmacogenomic Treatment of Schizophrenia
Bitsios, P., & Roussos, P. (2011) · Pharmacogenomics · doi:10.2217/pgs.10.206 · Cited by 18
Hall, K. T., Tolkin, B. R., Chinn, G. M., Kirsch, I., Kelley, J. M., Lembo, A. J., Kaptchuk, T. J., Kokkotou, E. G., Davis, R. B., & Conboy, L. A. (2014) · Brain and Behavior · doi:10.1002/brb3.294 · Cited by 18
Self-citationGenetic biomarkers of placebo response: what could it mean for future trial design?
Hall, K. T., & Kaptchuk, T. J. (2013) · Clinical Investigation · doi:10.4155/cli.13.8 · Cited by 17
Self-citationPlacebos in 19th century medicine: a quantitative analysis of the BMJ
Raicek, J., Stone, B. H., & Kaptchuk, T. J. (2012) · BMJ · doi:10.1136/bmj.e8326 · Cited by 17
Self-citationPersonalized Medicine and Ethics
Josko, D. (2014) · American Society for Clinical Laboratory Science · doi:10.29074/ascls.27.3.185 · Cited by 7
Cited by
(2020) · doi:10.1056/nejmra1907805 · Cited by 634
Kaptchuk, T. J., & Miller, F. G. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1504023 · Cited by 495
Self-citationThe placebo effect: From concepts to genes
Colagiuri, B., Schenk, L. A., Kessler, M. D., Dorsey, S. G., & Colloca, L. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.017 · Cited by 258
Placebo 2.0: the impact of expectations on analgesic treatment outcome
Bingel, U. (2020) · Pain · doi:10.1097/j.pain.0000000000001981 · Cited by 113
Penson, P. E., Mancini, G. B. J., Toth, P. P., Martin, S. S., Watts, G. F., Sahebkar, A., Mikhailidis, D. P., Banach, M., & on behalf of Lipid and Blood Pressure Meta‐Analysis Collaboration (LBPMC) Group & International Lipid Expert Panel (ILEP) (2018) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12344 · Cited by 110
Metadata
- Authors
- Hall, K. T., Loscalzo, J., & Kaptchuk, T. J.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 21
- Issue
- 5
- Pages
- 285-294
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2130655867
- Cited by
- 266
- References
- 99
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.